【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 21
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 22
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 25
3.2 Symptoms 28
4 Epidemiology 30
4.1 Disease Background 30
4.2 Risk Factors and Comorbidities 30
4.3 Global Trends 31
4.3.1 Prevalence 31
4.4 Forecast Methodology 33
4.4.1 Sources Used for One-Year Diagnosed Prevalence of Psoriasis 35
4.4.2 Sources Not Used 37
4.4.3 Forecast Assumptions and Methods, One-Year Diagnosed Prevalent Cases of Psoriasis 38
4.5 Epidemiological Forecast for Psoriasis (2014-2024) 40
4.5.1 One-Year Diagnosed Prevalent Cases of Psoriasis 40
4.5.2 Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 42
4.5.3 Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis 44
4.5.4 Age-Standardized One-Year Diagnosed Prevalent Cases of Psoriasis 46
4.5.5 One-Year Diagnosed Prevalent Cases of Psoriasis by Severity 47
4.6 Discussion 48
4.6.1 Epidemiological Forecast Insight 48
4.6.2 Limitations of the Analysis 49
4.6.3 Strengths of the Analysis 49
5 Disease Management 50
5.1 Diagnosis and Treatment Overview 50
5.1.1 Diagnosis 50
5.1.2 Leading Prescribed Drugs and Treatment Guidelines 51
5.1.3 Clinical Practice 54
5.2 US 54
5.3 5EU 59
5.4 Japan 62
5.5 India 65
6 Competitive Assessment 67
6.1 Overview 67
6.2 Strategic Competitor Assessment 68
6.3 Product Profiles – Major Brands 69
6.3.1 Enbrel (Etanercept) 69
6.3.2 Humira (Adalimumab) 76
6.3.3 Remicade (Infliximab) 82
6.3.4 Stelara (Ustekinumab) 89
6.3.5 Cosentyx (Secukinumab) 95
6.3.6 Taltz (Ixekizumab) 103
6.3.7 Otezla (Apremilast) 112
6.3.8 Taclonex and Enstilar (Calcipotriene and Betamethasone Dipropionate) 117
6.3.9 Methotrexate 123
6.3.10 Fumaderm (Fumaric Acid Esters) 128
6.3.11 Alzumab (Itolizumab) 133
6.3.12 Other Therapeutic Drug Classes Used in Psoriasis 136
6.3.13 Non-pharmacological Therapy 137
7 Unmet Need and Opportunity 140
7.1 Overview 140
7.2 Limited Patient Access Due to Drug Reimbursement Pattern 140
7.2.1 Unmet Need 140
7.2.2 Gap Analysis 141
7.2.3 Opportunity 142
7.3 Improved Drug Safety and Efficacy Profiles 142
7.3.1 Unmet Need 142
7.3.2 Gap Analysis 143
7.3.3 Opportunity 143
7.4 Education and Treatment of Psychological Factors Accompanying Psoriasis 144
7.4.1 Unmet Need 144
7.4.2 Gap Analysis 145
7.4.3 Opportunity 145
7.5 Physician Education About the Different Types of Psoriasis, not Just Plaque Psoriasis 146
7.5.1 Unmet Need 146
7.5.2 Gap Analysis 146
7.5.3 Opportunity 147
8 Pipeline Assessment 148
8.1 Overview 148
8.2 Clinical Trial Mapping 149
8.2.1 Clinical Trials by Country 149
8.3 Clinical Trials by Phase and Trial Status 150
8.4 Promising Drugs in Clinical Development 151
8.4.1 Xeljanz (Tofacitinib) 153
8.4.2 Brodalumab 160
8.4.3 Guselkumab (CNTO-1959) 168
8.4.4 Tildrakizumab 173
8.4.5 Piclidenoson (CF-101) 180
8.4.6 Additional Phase III Pipeline Products 185
8.4.7 Phase II Pipeline Products 185
8.4.8 Phase I Pipeline Products 187
8.5 Biosimilar Pipeline Products 188
8.5.1 Introduction 188
8.5.2 Hospira’s Inflectra Versus J&J’s Remicade in Key Autoimmune Diseases 189
8.5.3 Biosimilars in the Immunology Community 189
8.5.4 By the Numbers: Biosimilars in Development 190
8.5.5 The Impact of Biosimilars Will be Felt Throughout the Pharmaceutical Industry 194
8.5.6 Uptake of Biosimilars for Psoriasis is Expected to Vary by Market 195
8.5.7 Biosimilars Forecast 197
9 Current and Future Players 202
9.1 Overview 202
9.2 Trends in Corporate Strategy 205
9.3 Company Profiles 207
9.3.1 Johnson & Johnson 207
9.3.2 AbbVie 209
9.3.3 Amgen 211
9.3.4 Novartis 213
9.3.5 Pfizer 216
9.3.6 Eli Lilly 217
9.3.7 Merck 219
9.3.8 LEO Pharma 221
9.3.9 Celgene 224
9.3.10 Can-Fite Biopharma 225
10 Market Outlook 228
10.1 Global Markets 228
10.1.1 Forecast 228
10.1.2 Drivers and Barriers – Global Issues 233
10.2 US 236
10.2.1 Forecast 236
10.2.2 Key Events 242
10.2.3 Drivers and Barriers 242
10.3 5EU 244
10.3.1 Forecast 244
10.3.2 Key Events 250
10.3.3 Drivers and Barriers 250
10.4 Japan 252
10.4.1 Forecast 252
10.4.2 Key Events 256
10.4.3 Drivers and Barriers 256
10.5 India 258
10.5.1 Forecast 258
10.5.2 Key Events 261
10.5.3 Drivers and Barriers 261
11 Appendix 264
11.1 Bibliography 264
11.2 Abbreviations 281
11.3 Methodology 286
11.4 Forecasting Methodology 286
11.4.1 Diagnosed Psoriasis Patients 286
11.4.2 Percent Drug-Treated Patients 287
11.4.3 Drugs Included in Each Therapeutic Class 287
11.4.4 Launch and Patent Expiry Dates 288
11.4.5 General Pricing Assumptions 289
11.4.6 Individual Drug Assumptions 290
11.4.7 Generic Erosion 298
11.4.8 Pricing of Pipeline agents 298
11.5 Physicians and Specialists Included in this Study 299
11.6 Primary Research – Prescriber Survey 302
11.7 About the Authors 303
11.7.1 Author 303
11.7.2 Reviewer 303
11.7.3 Epidemiologist 304
11.7.4 Global Director of Therapy Analysis and Epidemiology 304
11.7.5 Global Head of Healthcare 305
11.8 About GlobalData 306
11.9 Disclaimer 306
【レポート販売概要】
■ タイトル：乾癬治療薬の世界市場予測・分析■ 英文：PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024
■ 発行日：2016年4月13日
■ 調査会社：GlobalData
■ 商品コード：GDHC119PIDR
■ 調査対象地域：グローバル
- 世界の関節リウマチ（RA）治療薬市場（2014-2018）About Rheumatoid Arthritis RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it ca …
- リアルタイム位置情報システム（RTLS）の世界市場RTLS refers to local positioning systems that are capable of providing real-time data to decision-makers, useful for the growth of their businesses. It also helps users streamline operations, increase resource (asset or personnel) utilization, and enhance productivity, which results in substantial increase in return on investment (ROI) and reduces the costs significantly. RTLS has already carved a …
- クラウドテレフォニー：技術、市場分析、予測（Cloud Telephony: Technology and Market Analysis & Forecast 2012-2017）When most people think of the Cloud, they think about infrastructure hosting as it is a cost effective alternative for enterprise application implementation and ongoing operations. However, few people understand the potential in Cloud Telephony, which represents a significant opportunity for replacement of traditional telecommunications systems, especially for small-to-medium businesses (SMB) comm …
- 商用車用電子制御エアサスペンション（ECAS） の世界市場2016-2020About ECAS ECAS is a system that provides variable height capabilities to a vehicle's suspension system, thus enhancing vehicular traction performance and providing ride height as well as loading flexibility. ECAS ensures that the vehicle chassis height is maintained at a preset level regardless of the nature of loading (live or dead) of the vehicle. Technavio’s analysts forecast the global electr …
- 世界の亜鉛市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of zinc, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing zinc production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: zinc production in th …
- 長型鉄鋼製品の世界市場：鉄筋、鋼鉄線材、鋼鉄管、形鋼About Steel Long Products Steel long products include rebars, wire rods, tubes, sections, hot rolled bars, and rails. Out of these, rebars accounted for the largest share of the market in 2015. Rebars are also known as reinforcement steel or reinforcing steel. Steel long products are used by industries such as infrastructure and construction, transmission and distribution, automobile, and general …
- ペラルゴン酸の世界市場Pelargonic Acid (n-Nonanoic acid ) (CAS 112-05-0) Market Research Report 2014 presents comprehensive data on pelargonic acid (n-nonanoic acid) markets globally and regionally (Europe, Asia, North America etc.) The report includes pelargonic acid (n-nonanoic acid) description, covers its application areas and related patterns. It overviews pelargonic acid (n-nonanoic acid) market, names pelargonic …
- 世界の患者介助用装置市場：車椅子、スクーター、医療用ベッド、バスルーム安全用品、機械装置、歩行補助具などThe global patient handling equipment market exhibits a lucrative growth potential for the next five years. The growth of this market is propelled by the rise in geriatric population and increasing lifestyle diseases such as diabetes and Cardiovascular Diseases (CVD) leading to increased disabilities. Further the market is driven by factors such as government policies promoting the use of patient …
- 世界のバーコードプリンタ市場2015The Global Barcode Printer Industry Report 2015 is a professional and in-depth study on the current state of the Barcode Printer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Barcode Printer market analysis is provided for the international markets including development trends, competitive lands …
- 世界のメタロセン（Metallocene）市場動向（2012-2016）TechNavio's analysts forecast the Global Metallocene market to grow at a CAGR of 6.89 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for polymers with low molecular distribution, and other characteristics, which in turn has led to an increased consumption of metallocene catalysts by polymer manufacturing industries. The Global …
- 二輪車用ABSの世界市場About Two-wheeler Anti-Braking System (ABS)The objective of ABS is to stop the vehicle without locking the wheels. ABS offer the braking force in pulses and allows the vehicle to come to a gradual halt, reducing the possibility of skidding, and reduces the braking distance. Technavio’s analysts forecast the global two-wheeler anti-braking system (ABS) market to grow at a CAGR of 59.75% during the …
- アジア太平洋の電動スリーホイーラー（三輪車）市場2016-2020About Electric Three Wheeler The global automotive industry consists of two categories of vehicles based on engine type: • Internal combustion engine (ICE) • Electric vehicle (EV) Conventional ICE-based three-wheelers are widely used commercial vehicles that transport goods and passengers. EVs are gaining popularity because ICE-based vehicles tend to emit carbon monoxide, oxides of nitrogen, hydro …
- 硝酸カリウムの世界市場動向The report presents detailed overview of the Potassium Nitrate market in the world and regions (CIS countries in particular) by contemplating and analyzing its various parameters. Firstly, brief introduction is provided. Thus, Potassium Nitrate properties, application areas and manufacturing technologies are considered. Further goes the analysis of global Potassium Nitrate market with emphasis on …
- 鉄道車両の世界市場およびインフラ分析：機関車、高速鉄道車両、貨物車両The global rolling stock market size is estimated to be at USD 45.73 Billion in 2015, which is projected to grow to USD 54.55 Billion by 2020, at a CAGR of 3.59%. Rail transportation offers an ideal, safe comfortable and environment friendly mobility solution for urban and interurban transportation systems. Increasing urbanization in emerging nations has strained the existing road, rail, and air i …
- 世界のコネクテッドカー市場2015-2025The increased demand for wireless connectivity, demonstrated by the high level of penetration of smartphones and tablets, drives the automotive industry to adjust to a new lifestyle consensus and incorporate in-vehicle internet connectivity solutions. Moreover, global regulatory mandates (eCall in EU, GLONASS in Russia, Contran 245 in Brazil) require the usage of telematics for safety purposes and …
